Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New York; Department of Emergency Medicine, Carolinas Medical Center, Charlotte, North Carolina.
Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New York; Department of Emergency Medicine, Albany Medical Center, Albany, New York.
J Emerg Med. 2021 Mar;60(3):273-284. doi: 10.1016/j.jemermed.2020.10.026. Epub 2020 Dec 9.
The current ST-elevation myocardial infarction (STEMI) vs. non-STEMI (NSTEMI) paradigm prevents some NSTEMI patients with acute coronary occlusion from receiving emergent reperfusion, in spite of their known increased mortality compared with NSTEMI without occlusion. We have proposed a new paradigm known as occlusion MI vs. nonocclusion MI (OMI vs. NOMI).
We aimed to compare the two paradigms within a single population. We hypothesized that STEMI(-) OMI would have characteristics similar to STEMI(+) OMI but longer time to catheterization.
We performed a retrospective review of a prospectively collected acute coronary syndrome population. OMI was defined as an acute culprit and either TIMI 0-2 flow or TIMI 3 flow plus peak troponin T > 1.0 ng/mL. We collected electrocardiograms, demographic characteristics, laboratory results, angiographic data, and outcomes.
Among 467 patients, there were 108 OMIs, with only 60% (67 of 108) meeting STEMI criteria. Median peak troponin T for the STEMI(+) OMI, STEMI(-) OMI, and no occlusion groups were 3.78 (interquartile range [IQR] 2.18-7.63), 1.87 (IQR 1.12-5.48), and 0.00 (IQR 0.00-0.08). Median time from arrival to catheterization was 41 min (IQR 23-86 min) for STEMI(+) OMI compared with 437 min (IQR 85-1590 min) for STEMI(-) OMI (p < 0.001). STEMI(+) OMI was more likely than STEMI(-) OMI to undergo catheterization within 90 min (76% vs. 28%; p < 0.001).
STEMI(-) OMI patients had significant delays to catheterization but adverse outcomes more similar to STEMI(+) OMI than those with no occlusion. These data support the OMI/NOMI paradigm and the importance of further research into emergent reperfusion for STEMI(-) OMI.
目前的 ST 段抬高型心肌梗死(STEMI)与非 ST 段抬高型心肌梗死(NSTEMI)的范式使得一些急性冠状动脉闭塞的 NSTEMI 患者无法接受紧急再灌注,尽管与无闭塞的 NSTEMI 相比,这些患者的死亡率更高。我们提出了一个新的范式,称为闭塞性心肌梗死与非闭塞性心肌梗死(OMI 与 NOMI)。
我们旨在在一个单一的人群中比较这两种范式。我们假设 STEMI(-)OMI 具有与 STEMI(+)OMI 相似的特征,但导管插入时间更长。
我们对前瞻性收集的急性冠脉综合征人群进行了回顾性分析。OMI 定义为急性罪犯血管,且 TIMI 血流 0-2 级或 TIMI 血流 3 级加肌钙蛋白 T 峰值>1.0ng/ml。我们收集了心电图、人口统计学特征、实验室结果、血管造影数据和结局。
在 467 例患者中,有 108 例 OMI,只有 60%(67/108)符合 STEMI 标准。STEMI(+)OMI、STEMI(-)OMI 和无闭塞组的肌钙蛋白 T 峰值中位数分别为 3.78(IQR 2.18-7.63)、1.87(IQR 1.12-5.48)和 0.00(IQR 0.00-0.08)。STEMI(+)OMI 组从到达至导管插入的中位时间为 41 分钟(IQR 23-86 分钟),而 STEMI(-)OMI 组为 437 分钟(IQR 85-1590 分钟)(p<0.001)。STEMI(+)OMI 组在 90 分钟内进行导管插入术的可能性大于 STEMI(-)OMI 组(76% vs. 28%;p<0.001)。
STEMI(-)OMI 患者的导管插入术延迟明显,但不良结局与 STEMI(+)OMI 更相似,而不是无闭塞的患者。这些数据支持 OMI/NOMI 范式和进一步研究 STEMI(-)OMI 紧急再灌注的重要性。